Chest imaging is not routinely recommended to diagnose coronavirus disease 2019 (COVID-19) in patients with mild features1
The diagnosis of COVID-19 is based on clinical symptoms and a positive reverse-transcription polymerase chain reaction (RT-PCR) assay.1 Chest radiography has been reported to have 25%–69% sensitivity, with limited data regarding specificity,2,3 compared with computed tomography (CT), which has a 44%–98% sensitivity and 25%–53% specificity.1,4
In patients with risk factors for disease progression, chest radiography, together with clinical symptoms, may inform whether to follow up in the community or to refer to secondary care
Risk factors for disease progression include age older than 65 years and comorbidities such as cardiovascular disease, diabetes, chronic respiratory disease, hypertension and immunocompromise.5 A low threshold for additional imaging is suggested for patients with risk factors.6 Hospital admission is considered for patients with moderate (e.g., dyspnea but blood oxygen saturation ≥ 94% on room air) and severe disease (e.g., marked tachypnea, hypoxemia, and substantial lung involvement on chest radiograph).6
A normal chest radiograph or CT scan does not rule out COVID-193
Chest imaging is often normal in patients with mild and early disease.3,4 Findings peak 6–13 days after symptom onset.3,4 Imaging features, though not specific, include consolidation and faint ground-glass opacities, particularly with a bilateral, peripheral, or posterior, lower zone distribution.3,4 (Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.200626/-/DC1). Differential diagnoses include other viral infections, adverse drug reaction and organizing pneumonia.1
Chest CT should be considered for some patients
In patients with new or worsening symptoms, chest CT can be useful to rule out complications such as a lung abscess, empyema, pulmonary embolism, or superimposed bacterial pneumonia.1,5 Chest CT may also be useful in moderately to severely symptomatic patients with a negative RT-PCR to either suggest the diagnosis of COVID-19 (if typical imaging features are found) or exclude alternative diagnoses.1,5
Repeat imaging is not indicated unless there is a change in clinical status, such as increased respiratory distress, or complications are suspected5
Repeat imaging increases patients’ radiation exposure and the risk of health care providers and other patients contracting the virus. Daily chest radiography in stable patients with COVID-19, including intubated patients, does not lead to improved outcomes.1
Footnotes
Competing interests: None declared.
This article has been peer reviewed.
Online resources available for chest imaging and management of COVID-19 are available in Appendix 2, www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.200626/-/DC1
In this issue
Article tools
Jump to section
- Article
- Chest imaging is not routinely recommended to diagnose coronavirus disease 2019 (COVID-19) in patients with mild features1
- In patients with risk factors for disease progression, chest radiography, together with clinical symptoms, may inform whether to follow up in the community or to refer to secondary care
- A normal chest radiograph or CT scan does not rule out COVID-193
- Chest CT should be considered for some patients
- Repeat imaging is not indicated unless there is a change in clinical status, such as increased respiratory distress, or complications are suspected5
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.
More in this TOC Section
Similar Articles
Collections
